Henricus Kunst

Prof. Dr. Henricus Kunst

1. Department of Otorhinolaryngology and Head & Neck Surgery, Radboudumc, Nijmegen, The Netherlands
+2

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 January 2019 in Cancers
Verified
Journal Article
Open access
PDF file
JRJohannes Rijken
Johannes Rijken
LHLeonie T. van Hulsteijn
Leonie T. van Hulsteijn
ODOlaf M. Dekkers
Olaf M. Dekkers
NNNicolasine D. Niemeijer
Nicolasine D. Niemeijer
CLChristiaan René Leemans
Christiaan René Leemans
EHErik F. Hensen
Erik F. Hensen
Germline mutations in succinate dehydrogenase subunit B and D (SDHB and SDHD) are predisposed to hereditary paraganglioma (PGL) and pheochromocytoma (PHEO). The phenotype of pathogenic variants varies according to the causative gene. In this retrospective study, we estimate the mortality of a nationwide cohort of SDHB variant carriers and that of a large cohort of SDHD variant carriers and compare it to the mortality of a matched cohort of the general Dutch population. A total of 192 SDHB variant carriers and 232 SDHD variant carriers were included in this study. The Standard Mortality Ratio (SMR) for SDHB mutation carriers was 1.89, increasing to 2.88 in carriers affected by PGL. For SDHD variant carriers the SMR was 0.93 and 1.06 in affected carriers. Compared to the general population, mortality seems to be increased in SDHB variant carriers, especially in those affected by PGL. In SDHD variant carriers, the mortality is comparable to that of the general Dutch population, even if they are affected by PGL. This insight emphasizes the significance of DNA-testing in all PGL and PHEO patients, since different clinical risks may warrant gene-specific management strategies.

10 August 2021 in Journal of Neurology
Verified
Journal Article
Open access
PDF file
JSJoost J. A. Stultiens
Joost J. A. Stultiens
NGNils Guinand
Nils Guinand
VRVincent Van Rompaey
Vincent Van Rompaey
Angelica Perez FornosAngelica Perez Fornos
Angelica Perez Fornos
Henricus KunstHenricus Kunst
Henricus Kunst
Raymond van de BergRaymond van de Berg
Raymond van de Berg
Background: Certain cases of superior semicircular canal dehiscence or benign paroxysmal positional vertigo can be treated by plugging of the affected semicircular canal. However, the extent of the impact on vestibular function and hearing during postoperative follow-up is not known. Objective: To evaluate the evolution of vestibular function and hearing after plugging of a semicircular canal. Methods: Six patients underwent testing before and 1 week, 2 months, and 6 months after plugging of the superior or posterior semicircular canal. Testing included caloric irrigation test, video Head Impulse Test (vHIT), cervical and ocular Vestibular Evoked Myogenic Potentials (VEMPs) and audiometry. Results: Initially, ipsilateral caloric response decreased in all patients and vHIT vestibulo-ocular reflex (VOR) gain of each ipsilateral semicircular canal decreased in 4/6 patients. In 4/6 patients, postoperative caloric response recovered to > 60% of the preoperative value. In 5/6 patients, vHIT VOR gain was restored to > 85% of the preoperative value for both ipsilateral non-plugged semicircular canals. In the plugged semicircular canal, this gain decreased in 4/5 patients and recovered to > 50% of the preoperative value. Four patients preserved cervical and ocular VEMP responses. Bone conduction hearing deteriorated in 3/6 patients, but recovered within 6 months postoperatively, although one patient had a persistent loss of 15 dB at 8 kHz. Conclusion: Plugging of a semicircular canal can affect both vestibular function and hearing. After initial deterioration, most patients show recovery during follow-up. However, a vestibular function loss or high-frequency hearing loss can persist. This stresses the importance of adequate counseling of patients considering plugging of a semicircular canal.

21 February 2024 in Cancers
Verified
Journal Article
Open access
PDF file
PRPawan Kishore Ravindran
Pawan Kishore Ravindran
MKMax Keizer
Max Keizer
Henricus KunstHenricus Kunst
Henricus Kunst
ICInge Compter
Inge Compter
JAJasper Van Aalst
Jasper Van Aalst
Yasin TemelYasin Temel
Yasin Temel
Surgery and radiotherapy are key elements to the treatment of skull-base chondrosarcomas; however, there is currently no consensus regarding whether or not adjuvant radiotherapy has to be administered. This study searched the EMBASE, Cochrane, and PubMed databases for clinical studies evaluating the long-term prognosis of surgery with or without adjuvant radiotherapy. After reviewing the search results, a total of 22 articles were selected for this review. A total of 1388 patients were included in this cohort, of which 186 received surgery only. With mean follow-up periods ranging from 39.1 to 86 months, surgical treatment provided progression-free survival (PFS) rates ranging from 83.7 to 92.9% at 3 years, 60.0 to 92.9% at 5 years, and 58.2 to 64.0% at 10 years. Postoperative radiotherapy provides PFS rates ranging between 87 and 96.2% at 3 years, 57.1 and 100% at 5 years, and 67 and 100% at 10 years. Recurrence rates varied from 5.3% to 39.0% in the surgery-only approach and between 1.5% and 42.90% for the postoperative radiotherapy group. When considering prognostic variables, higher age, brainstem/optic apparatus compression, and larger tumor volume prior to radiotherapy were found to be significant factors for local recurrence.

9 April 2019 in Molecular Genetics and Genomics
Verified
Journal Article
Closed access
PDF file
HVHanne Valgaeren
Hanne Valgaeren
MSManou Sommen
Manou Sommen
MBMatthias Beyens
Matthias Beyens
GVGeert Vandeweyer
Geert Vandeweyer
ASAnne Schepers
Anne Schepers
GCGuy Van Camp
Guy Van Camp

25 April 2021 in European Archives of Oto-Rhino-Laryngology
Verified
Journal Article
Open access
PDF file
WMWilhelmina L. van der Meer
Wilhelmina L. van der Meer
JWJérôme J. Waterval
Jérôme J. Waterval
Henricus KunstHenricus Kunst
Henricus Kunst
CMCristina Mitea
Cristina Mitea
SPSjoert A. H. Pegge
Sjoert A. H. Pegge
APAlida Annechien Postma
Alida Annechien Postma
Background and purpose: Necrotizing external otitis (NEO) is a serious complication of external otitis. NEO can be classified according to—anterior, medial, posterior, intracranial, and contralateral—extension patterns. Currently there is no consensus on the optimal imaging modality for the identification of disease extension. This study compares NEO extension patterns on MR and CT to evaluate diagnostic comparability. Methods: Patients who received a CT and MR within a 3-month interval were retrospectively examined. Involvement of subsites and subsequent spreading patterns were assessed on both modalities by a radiologist in training and by a senior head and neck radiologist. The prevalence of extension patterns on CT and MR were calculated and compared. Results: All 21 included NEO cases showed an anterior extension pattern on CT and MR. Contrary to MR, medial extension was not recognized on CT in two out of six patients, and intracranial extension in five out of eight patients. The posterior extension pattern was not recognized on MR. Overall, single anterior extension pattern (62%) is more prevalent than multiple extension patterns (38%). Conclusion: All anterior NEO extension pattern were identified on CT as well as MR. However, the medial and intracranial spreading patterns as seen on MR could only be identified on CT in a small number of patients. The posterior spreading pattern can be overlooked on MR. Thus, CT and MR are complimentary for the initial diagnosis and work-up of NEO as to correctly delineate disease extent through the skull base.

6 December 2022 in Neurosurgical Review
Verified
Journal Article
Closed access
PDF file
Selçuk PekerSelçuk Peker
Selçuk Peker
YSYavuz Samanci
Yavuz Samanci
IOInan Erdem Ozdemir
Inan Erdem Ozdemir
Henricus KunstHenricus Kunst
Henricus Kunst
DEDaniëlle Berty Petra Eekers
Daniëlle Berty Petra Eekers
Yasin TemelYasin Temel
Yasin Temel